![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: B3GALNT1 (CAeditome ID:8706) |
Gene summary for B3GALNT1 |
![]() |
Gene information | Gene symbol | B3GALNT1 | Gene ID | 8706 |
Gene name | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | |
Synonyms | B3GALT3|GLCT3|GLOB|Gb4Cer|P|P1|beta3Gal-T3|galT3 | |
Cytomap | 3q26.1 | |
Type of gene | protein-coding | |
Description | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1P antigen synthaseP blood group globosideUDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 3 (Globoside blood group)UDP-GalNAc:betaGlcNAc beta-1,3-galactosaminyltransferase, polypepti | |
Modification date | 20210518 | |
UniProtAcc | O75752 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
Top |
RNA A-to-I events for B3GALNT1 |
![]() |
![]() |
![]() |
![]() |
CAediting_319744(161084669, -), CAediting_319745(161084710, -), CAediting_319746(161090022, -), CAediting_319747(161090043, -), CAediting_319748(161092871, -), CAediting_319749(161092898, -), CAediting_319750(161093029, -), |
Top |
RNA editing positional annotations for B3GALNT1 using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
CAediting_319746 | chr3_161090022_- | nonsynonymous SNV | ENST00000460353.1 | c.A248G | p.D83G | D | . | D |
CAediting_319747 | chr3_161090043_- | nonsynonymous SNV | ENST00000460353.1 | c.A227G | p.Q76R | D | . | D |
![]() |
CAeditome ID | Position | Variant type |
CAediting_319744 | chr3_161084669_- | UTR3 |
CAediting_319745 | chr3_161084710_- | UTR3 |
CAediting_319746 | chr3_161090022_- | exonic |
CAediting_319747 | chr3_161090043_- | exonic |
CAediting_319748 | chr3_161092871_- | ncRNA_intronic |
CAediting_319749 | chr3_161092898_- | ncRNA_intronic |
CAediting_319750 | chr3_161093029_- | ncRNA_intronic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
CAediting_319746 | chr3_161090022_- | SINE | Alu | AluSx |
CAediting_319747 | chr3_161090043_- | SINE | Alu | AluSx |
CAediting_319748 | chr3_161092871_- | SINE | Alu | AluY |
CAediting_319749 | chr3_161092898_- | SINE | Alu | AluY |
CAediting_319750 | chr3_161093029_- | SINE | Alu | AluY |
Top |
RNA A-to-I editing events in the alternative splicing sites for B3GALNT1 |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for B3GALNT1 |
![]() * The grey color means N/A. |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for B3GALNT1 |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for B3GALNT1 |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000320474 | hsa-miR-205-5p | 161084668 | 161084674 | 7mer-m8 | 161084667 | 161084689 | 143.00 | -14.13 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000320474 | hsa-miR-4512 | 161084663 | 161084670 | 8mer-1a | 161084663 | 161084686 | 146.00 | -15.09 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000392779 | hsa-miR-205-5p | 161084668 | 161084674 | 7mer-m8 | 161084667 | 161084689 | 143.00 | -14.13 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000392779 | hsa-miR-4512 | 161084663 | 161084670 | 8mer-1a | 161084663 | 161084686 | 146.00 | -15.09 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000320474 | hsa-miR-3119 | 161084666 | 161084671 | 6mer | 161084665 | 161084683 | 152 | -17.82 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000320474 | hsa-miR-3119 | 161084666 | 161084671 | 6mer | 161084665 | 161084683 | 152 | -17.82 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000320474 | hsa-miR-3158-3p | 161084663 | 161084670 | 8mer-1a | 161084663 | 161084684 | 149 | -14.63 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000320474 | hsa-miR-3158-3p | 161084663 | 161084670 | 8mer-1a | 161084663 | 161084684 | 149 | -14.63 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000392779 | hsa-miR-3119 | 161084666 | 161084671 | 6mer | 161084665 | 161084683 | 152 | -17.82 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000392779 | hsa-miR-3119 | 161084666 | 161084671 | 6mer | 161084665 | 161084683 | 152 | -17.82 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000392779 | hsa-miR-3158-3p | 161084663 | 161084670 | 8mer-1a | 161084663 | 161084684 | 149 | -14.63 |
CAediting_319744 | chr3_161084669_- | ENSG00000169255.12 | ENST00000392779 | hsa-miR-3158-3p | 161084663 | 161084670 | 8mer-1a | 161084663 | 161084684 | 149 | -14.63 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_980496 | chr14_31014685_- | ENSG00000169255.12 | ENST00000320474 | hsa-miR-624-3p | 161084731 | 161084736 | 6mer | 161084730 | 161084752 | 142 | -17.62 |
CAediting_393 | chr1_1167164_+ | ENSG00000169255.12 | ENST00000320474 | hsa-miR-200b-3p | 161084784 | 161084790 | 7mer-m8 | 161084783 | 161084801 | 144 | -11.48 |
CAediting_980496 | chr14_31014685_- | ENSG00000169255.12 | ENST00000392779 | hsa-miR-624-3p | 161084731 | 161084736 | 6mer | 161084730 | 161084752 | 142 | -17.62 |
CAediting_393 | chr1_1167164_+ | ENSG00000169255.12 | ENST00000392779 | hsa-miR-200b-3p | 161084784 | 161084790 | 7mer-m8 | 161084783 | 161084801 | 144 | -11.48 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_393 | chr1_1167164_+ | ENSG00000169255.12 | ENST00000320474 | hsa-miR-200b-3p | 161085241 | 161085247 | 7mer-m8 | 161085240 | 161085261 | 151 | -11.7 |
CAediting_393 | chr1_1167164_+ | ENSG00000169255.12 | ENST00000392779 | hsa-miR-200b-3p | 161085241 | 161085247 | 7mer-m8 | 161085240 | 161085261 | 151 | -11.7 |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for B3GALNT1 |
![]() * Click on the image to enlarge it in a new window. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
CAediting_319744 | ENST00000320474.7 | chr3_161084669_- | -881.00 | -881.30 | -885.10 |
CAediting_319745 | ENST00000320474.7 | chr3_161084710_- | -885.50 | -881.30 | -885.10 |
CAediting_319744 | ENST00000392779.5 | chr3_161084669_- | -889.30 | -889.60 | -894.20 |
CAediting_319745 | ENST00000392779.5 | chr3_161084710_- | -894.60 | -889.60 | -894.20 |
CAediting_319744 | ENST00000392781.5 | chr3_161084669_- | -1031.40 | -1031.70 | -1034.30 |
CAediting_319745 | ENST00000392781.5 | chr3_161084710_- | -1034.50 | -1031.70 | -1034.30 |
CAediting_319746 | ENST00000392781.5 | chr3_161090022_- | -1031.90 | -1031.70 | -1034.30 |
CAediting_319747 | ENST00000392781.5 | chr3_161090043_- | -1031.10 | -1031.70 | -1034.30 |
CAediting_319746 | ENST00000460353.1 | chr3_161090022_- | -188.10 | -188.70 | -187.40 |
CAediting_319747 | ENST00000460353.1 | chr3_161090043_- | -188.00 | -188.70 | -187.40 |
CAediting_319746 | ENST00000473142.4 | chr3_161090022_- | -170.80 | -171.40 | -171.00 |
CAediting_319747 | ENST00000473142.4 | chr3_161090043_- | -171.60 | -171.40 | -171.00 |
CAediting_319746 | ENST00000476999.4 | chr3_161090022_- | -212.60 | -213.20 | -212.40 |
CAediting_319747 | ENST00000476999.4 | chr3_161090043_- | -212.60 | -213.20 | -212.40 |
CAediting_319746 | ENST00000492353.4 | chr3_161090022_- | -200.70 | -201.60 | -201.20 |
CAediting_319747 | ENST00000492353.4 | chr3_161090043_- | -202.10 | -201.60 | -201.20 |
CAediting_319746 | ENST00000494173.4 | chr3_161090022_- | -249.70 | -249.70 | -249.70 |
CAediting_319747 | ENST00000494173.4 | chr3_161090043_- | -250.20 | -249.70 | -249.70 |
CAediting_319747 | ENST00000478383.4 | chr3_161090043_- | -174.80 | -172.20 | -174.80 |
Top |
Relation with ADAR for B3GALNT1 |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for B3GALNT1 |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for B3GALNT1 |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for B3GALNT1 |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for B3GALNT1 |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |